Ambassador-at-Large Deborah L. Birx, M.D., is the Coordinator of the United States Government Activities to Combat HIV/AIDS and U.S. Special Representative for Global Health diplomacy. Her three-decade-long career has focused on HIV/AIDS immunology, vaccine research, and global health. As the U.S. Global AIDS Coordinator, Ambassador Birx oversees the implementation of The U.S. President’s Emergency Plan for AIDS Relief and all U.S. government engagement with the Global Fund to Fight AIDS, Tuberculosis and Malaria. Serving as the U.S. Special Representative for Global Health Diplomacy, she aligns the U.S. government’s diplomacy with foreign assistance programs that address global health challenges and accelerate progress toward achieving an AIDS-free generation; ending preventable child and maternal deaths; and preventing, detecting, and responding to infectious disease threats.
Simon Bland, M.S., CBE, joined UNAIDS in 2013 as its Director in New York. Prior to joining UNAIDS, Mr. Bland was a senior civil servant in the United Kingdom’s Department for International Development (DFID) and, most recently, headed its Global Funds Department. In this role he was responsible for the United Kingdom’s policies, programs, financial management, and shareholder relations with Global Funds and Innovative Finance in health and education. He represented the United Kingdom on the Boards of the Global Fund to Fight AIDS, Tuberculosis and Malaria; Gavi; UNITAID; and the Global Partnership for Education. From 2011 to 2013, Mr. Bland was Chair of the Board of the Global Fund to
Fight AIDS, Tuberculosis and Malaria and oversaw a substantial transformation culminating in the introduction of a new funding model and strengthened partnership approach. Mr. Bland’s early background was in marine sciences and natural resources management, later branching out into development economics and management. He has spent most of the past 30 years working in developing countries in Africa, Asia, and the Pacific. He has led DFID country programs in Russia, Ukraine, Kenya, and Somalia before moving to Geneva to work on global health, education, and humanitarian affairs. Mr. Bland now sits on the Boards of Roll Back Malaria, Malaria No More (UK), and the Global Health Council, and serves on the Programme Advisory Council of Health Right International. Mr. Bland was made a Commander of the British Empire in the Queen’s Birthday Honours list in 2013 for service to Global Health.
Jo Ivey Boufford, M.D., is Co-Chair of the Forum on Public–Private Partnerships for Global Health and Safety and immediate past President of The New York Academy of Medicine. As of January 1, 2018, she is a Clinical Professor of Global Public Health at the College of Global Public Health at New York University, where she is also Professor of Public Service, Health Policy and Management at the Robert F. Wagner Graduate School of Public Service and Clinical Professor of Pediatrics at the New York University School of Medicine. She served as Dean of the Robert F. Wagner Graduate School of Public Service at New York University from June 1997 to November 2002. Prior to that, she served as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS) from November 1993 to January 1997, and as Acting Assistant Secretary from January 1997 to May 1997. While at HHS, she was the U.S. representative on the Executive Board of the World Health Organization (WHO) from 1994 to 1997. She served in a variety of senior positions and as President of the New York City Health and Hospitals Corporation, the largest municipal system in the United States, from December 1985 until October 1989. Dr. Boufford was awarded a Robert Wood Johnson Health Policy Fellowship at the National Academy of Medicine in Washington, DC, for 1979–1980. She currently serves on the boards of the United Hospital Fund and the Health Effects Institute. She was elected to membership in the National Academy of Medicine in 1992 and served on its Board on Global Health and Board on African Science Academy Development. She served two 4-year terms as the Foreign Secretary of the National Academy of Medicine between 2010 and 2014 and was elected to membership for the National Academy of Public Administration in 2015. She received an Honorary Doctorate of Science degrees from the State University of New York, Brooklyn (1992), New York Medical College (2007), Pace University (2011), and Toledo University (2012).
She has been a Fellow of The New York Academy of Medicine since 1988 and a Trustee since 2004. Dr. Boufford attended Wellesley College for 2 years and received her B.A. in Psychology magna cum laude from the University of Michigan, and her M.D., with distinction, from the University of Michigan Medical School. She is board certified in pediatrics.
Caroline Bressan, M.B.A., is the Director of Social Investments at Open Road Alliance, which she joined in 2015. She leads Open Road’s Social Investment team, where she manages both the grant and loan portfolios, funding unexpected roadblocks for nonprofits and social enterprises. Prior to Open Road, Ms. Bressan was an Investment Principal at Dalberg Capital, the investment advisory wing of Dalberg. There, she focused on Dalberg Capital’s impact investment advisory offerings, building a pipeline of investment opportunities in sub-Saharan Africa, specifically in energy and agriculture. Ms. Bressan also worked on the design and structuring of innovative financing mechanisms, including impact bonds and social impact insurance. Previously, Ms. Bressan was an Investment Officer at Calvert Impact Capital (formerly Calvert Foundation) where she managed its $20 million portfolio, mainly focused on Latin America. At Calvert, she originated and managed a pipeline of lending and investment deals focused on the sustainable trade, social enterprise, and financial inclusion sectors. In addition, Ms. Bressan designed and launched a revolving line of credit product, which was the first of its kind for Calvert, and helped launch the international component of the Women Investing in Women Initiative (WIN-WIN). She also sat on the investment committee of the Haitian Emergency Liquidity Fund, created to provide funding to microfinance institutions in the aftermath of the 2009 earthquake. Ms. Bressan received her M.B.A. from Dartmouth’s Tuck School of Business and holds a bachelor’s degree in Business Administration from the University of Michigan. She speaks English and Spanish.
Deena L. Buford, M.D., M.Sc., is currently the Global Medical Director of the Medicine and Occupational Health Department for ExxonMobil Corporation. The department delivers services to more than 80,000 ExxonMobil and affiliate employees worldwide. In addition to traditional work-related occupational health services, their service portfolio includes emergency response, travel medicine, industrial hygiene, drug testing, infectious disease support, and health promotion services delivered across a global network of more than 90 clinics. Dr. Buford completed her undergraduate education at Duke University, obtaining degrees in Psychology and Chemistry. While at Duke, she received an undergraduate research grant from the Department of Neuroanatomy, and her work contributed to a publication in the Journal of Comparative Neurology. She attended
medical school at Meharry Medical College in Nashville, Tennessee, completed a residency in Occupational Medicine, and obtained a Master’s of Science in Public Health at the same institution. She is board certified in Occupational Medicine. Dr. Buford is a member of the Alpha Omega Alpha Medical Honor Society, the American College of Occupational and Environmental Medicine, and the American Public Health Association. She also serves on the Society of Petroleum Engineers Health, Safety, Security, Environmental and Social Responsibility Committee and the International Corporate Health Leadership Council.
Siddharth “Sid” Chatterjee, M.P.P., has been the Resident Coordinator and Resident Representative in Kenya since August 2016. Prior to this appointment, he served as the Representative for the United Nations Population Fund (UNFPA) for Kenya (2014–2016). Before he joined UNFPA, he was the Chief Diplomat and Head of Strategic Partnerships and Resource Mobilization at the International Federation of the Red Cross and Red Crescent Societies (2011–2014). He was Regional Director for United Nations Office of Project Services in the Middle East, Europe, and Central Asian Republics (2009–2010). Mr. Chatterjee has spent most of his career in the United Nations (UN), working in fragile states and complex emergencies, serving in various capacities with the UN Mission in Iraq; the United Nations Children’s Fund offices in Somalia, South Sudan, Sudan (Darfur), and Indonesia; and the UN Peace Keeping Operations in Bosnia, Herzegovina, and Iraqi Kurdistan. A frequent contributor to humanitarian and development issues, he has a blog in Huffington Post and Reuters, and his articles have been featured in The Guardian, CNN, Al Jazeera, and the Global Observatory, as well as in mainstream Kenyan and Indian journals. In his early career, Mr. Chatterjee served in the Special Forces of the Indian Army. He holds a Master’s in Public Policy from the Woodrow Wilson School of Public and International Affairs at Princeton University and a B.Sc. from the National Defence Academy in India.
H. Westley Clark, M.D., M.P.H., J.D., is currently the Dean’s Executive Professor of Public Health at Santa Clara University in Santa Clara, California. He is formerly the Director of the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (HHS), where he led the agency’s national effort to provide effective and accessible treatment to all Americans with addictive disorders. Dr. Clark was also the former chief of the Associated Substance Abuse Programs at the U.S. Department of Veterans Affairs Medical Center in San Francisco, California, and a former associate clinical professor in the Department of Psychiatry at the University of California, San Francisco. Dr. Clark served as a senior
program consultant to the Robert Wood Johnson Substance Abuse Policy Program and as a co-investigator on a number of the National Institute on Drug Abuse–funded research grants. He worked for Senator Edward Kennedy as a health counsel on the U.S. Senate Committee of Labor and Human Resources. He has received numerous awards for his contributions to the field of substance abuse treatment, including the 2015 James Ralph Memorial Award for Outstanding Public Service from the Black Psychiatrists of America; a 2015 Annual Award, American Society of Addiction Medicine; a 2013 Friend of the Field Award from AATOD; a 2013 Life Time Achievement Award, American Public Health Association, ATOD section; the 2013 Public Policy Award, American Society of Addiction Medicine; the 2011 Gold Key Award, National Council on Alcoholism and Drug Dependence; a 2008 President Rank of Distinguished Executive Award; and a 2003 President Rank of Meritorious Executive Award in the Senior Executive Service. He was awarded the 2008 John P. McGovern Award from the American Society of Addiction Medicine for his contributions toward increased understanding of the relationship between addiction and society. Other awards include HHS’s Award for Distinguished Service and the Vernelle Fox Award from the California Society of Addiction Medicine for Excellence in Addiction Medicine, Education, and Public Service in 2000. Dr. Clark received a B.A. in Chemistry from Wayne State University in Detroit, Michigan. He holds a Medical Degree and a Master’s in Public Health from the University of Michigan, Ann Arbor, where he completed a Psychiatric Residency at University Hospital, Neuropsychiatric Institute. He obtained his Juris Doctorate from Harvard University Law School and completed a 2-year Substance Abuse Fellowship at the U.S. Department of Veterans Affairs Medical Center in San Francisco. Dr. Clark received his board certification from the American Board of Psychiatry and Neurology in Psychiatry and subspecialty certifications in Addiction Psychiatry. Dr. Clark is licensed to practice medicine in California, Maryland, Massachusetts, and Michigan. He is also a member of the Washington, DC, bar.
Santiago Cornejo, M.A., is the Director for Immunization Financing and Sustainability who works with Gavi, the Vaccine Alliance, to enable the sustainability of immunization achievements in Gavi’s transitioning countries. Mr. Cornejo coordinates the implementation and Alliance support to Gavi’s cofinancing, eligibility, and transition policies. Mr. Cornejo joined Gavi in 2008, and during his time he has led the development of Gavi’s policies, including cofinancing, transition and eligibility, and transparency and accountability. Mr. Cornejo also served as Senior Portfolio Manager for Latin America and Lusophone (Portuguese speaking) countries and was acting Director for Country Grants and Renewals, overseeing Gavi’s
review process for country proposals, monitoring progress and renewal of support. Mr. Cornejo has more than 18 years of cumulative work experience in the field of health and immunization financing. He started his career in 1999 with the Pan American Health Organization in Washington, DC. He has successively held roles with the World Health Organization, the Vaccine Fund, and the World Bank. Mr. Cornejo also worked in academia at the Center for Global Health at George Washington University. He holds a master’s degree in International Economic Development with a specialization in International Public Health Policy from George Washington University.
Jennifer Esposito, M.S., is an executive with more than 20 years of experience in global health care IT and the health and life sciences industry. Ms. Esposito worked for more than 13 years at GE Healthcare and is now Worldwide General Manager of Health and Life Sciences at Intel Corporation. Ms. Esposito has led commercial organizations, sales, marketing and service operations, profit and loss statements, as well as both upstream and downstream strategy and marketing—in all cases driving new business growth and organizational transformation. Ms. Esposito has extensive experience working with governments, intergovernmental agencies, industry organizations, and others to influence and drive policy related to the use of information and communication technologies in health care and health security. At Intel, Ms. Esposito leads a worldwide team of industry and technology leaders, subject-matter experts, account executives, scale managers, industry technical specialists, and solution architects to develop solutions that use information and communication technology to solve the most pressing challenges facing the health and life sciences industry (e.g., making personalized medicine a practical reality, securing health systems from data breaches, and integrating digital solutions in hospitals and health systems to improve care, access, and lower costs). Together with the Novartis Foundation, Ms. Esposito co-chairs the UN Broadband Commission for Sustainable Development Working Group on Digital Health for Non-Communicable Diseases. Ms. Esposito is on the Steering Committee of the Global Health Security Agenda Private Sector Roundtable (PSRT) and chairs the PSRT’s Technology and Analytics Working Group. Ms. Esposito holds a graduate degree in Epidemiology and Biostatistics from the Dartmouth Institute for Health Policy and Clinical Practice, and a B.A. from Dartmouth College. Ms. Esposito is a certified Six Sigma Black Belt and is a member of the American Association of Physicists in Medicine.
Tim Evans, M.D., D.Phil., is the Senior Director of Health, Nutrition, and Population at the World Bank Group. From 2010 to 2013, Dr. Evans was
dean of the James P. Grant School of Public Health at BRAC University in Bangladesh and senior advisor to the BRAC Health Program. From 2003 to 2010, he was Assistant Director General at the World Health Organization (WHO). Prior to this, he served as director of the Health Equity Theme at the Rockefeller Foundation. Earlier in his career he was an attending physician of internal medicine at Brigham and Women’s Hospital in Boston and was assistant professor in international health economics at the Harvard T.H. Chan School of Public Health. He is a board member of a number of international health alliances. Dr. Evans has been at the forefront of advancing global health equity and strengthening health systems delivery for more than 20 years. At WHO, he led the Commission on Social Determinants of Health and oversaw the production of the annual World Health Report. He has been a cofounder of many partnerships, including the Global Alliance on Vaccines and Immunization, as well as efforts to increase access to HIV treatment for mothers and innovative approaches to training community-based midwives in Bangladesh. Dr. Evans received his medical degree from McMaster University in Canada and was a research and internal medicine resident at Brigham and Women’s Hospital. He earned a D.Phil. in Agricultural Economics from University of Oxford, where he was a Rhodes scholar.
John Fitzsimmons, MURP, has a public health career in the expanded program of immunizations, including periods of service with the Pan American Health Organization/World Health Organization (1981–1994, 2001–2007, and from 2016 to present) with the South-East Asia Regional Office of the World Health Organization in New Delhi (1997–2001) and with the U.S. Centers for Disease Control and Prevention in Atlanta (2007–2016). In these technical, operational, and vaccine supply chain positions he supported achievements by national immunization programs to meet regional and global public health goals for polio eradication, measles and rubella elimination, and the control of vaccine-preventable diseases overall. Mr. Fitzsimmons holds a master’s degree from the University of Pittsburgh, and his published work focuses on the sustainability of national immunization programs and vaccine supply chains.
Amanda Glassman, M.Sc., is Chief Operating Officer and Senior Fellow at the Center for Global Development (CGD) and also serves as Secretary of the board. Her research focuses on priority setting, resource allocation, and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at CGD from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world. Prior to joining
CGD, Ms. Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015, and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005 to 2007, Ms. Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Ms. Glassman designed, supervised, and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the U.S. Agency for International Development. Ms. Glassman holds an M.Sc. from the Harvard T.H. Chan School of Public Health and a B.A. from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and co-author of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development, 2016); From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings, 2010); and The Health of Women in Latin America and the Caribbean (World Bank, 2001).
Naresh Goel, MBBS, M.D., earned both his MBBS (Bachelor of Medicine and Bachelor of Surgery) in 1978 and his M.D. in 1990 from Maulana Azad Medical College. He has extensive experience in the field of Public Health with government, nongovernmental organizations (NGOs), and United Nations agencies, having extensively traveled throughout the world for public health programs. During his initial posting, he served as Chief Medical Officer with the Directorate of Family Welfare, Government of Delhi (for Pulse Polio Program), and Lok Nayak Hospital from 1991 to 2001. He was then posted as Assistant Commissioner (Public Health) and Assistant Commissioner (NGO) in the Ministry of Health and Family Welfare from 2001 to 2004. For more than 2 years, from November 2004 to December 2006, he worked with the World Health Organization India as the Surveillance and Monitoring Officer in immunization programs supporting the national government. Dr. Goel then served as Assistant Commissioner (Universal Immunization Programme) in the Ministry of Health and Family Welfare from 2007 to 2010. He now serves as Deputy Director General at the National AIDS Control Organisation and is in charge of mainstreaming, including public–private partnerships (PPPs) for advancing the cause of HIV/AIDS control. He is also project coordinator of the Labs for Life project, a PPP initiative of the government of India and the U.S. Centers for Disease Control and Prevention. Recently, his major responsibilities are the scale-up of viral load testing throughout India in PPPs and framing rules for the HIV/AIDS Act.
Allison Goldberg, Ph.D., is the Executive Director of the Anheuser-Busch (AB) InBev Foundation. Dr. Goldberg, who held the position of Vice President, Strategy & Programs from May 2017 to July 2018, is responsible for overseeing the execution of the Foundation’s strategic vision according to its guiding principles of transparency, supporting local leadership, and maintaining academic integrity. Dr. Goldberg also serves as Secretary of the Foundation’s Board of Directors. Previously, Dr. Goldberg was Director of Global Corporate Affairs at AB InBev. In this role, Dr. Goldberg worked across AB InBev and with outside experts to develop the architecture and strategy for the Global Smart Drinking Goals and the Together for Safer Roads initiative, a cross-industry coalition working to improve road safety globally. She represented AB InBev on the Health and Medicine Division’s Forum on Public–Private Partnerships for Global Health and Safety and managed AB InBev’s Global Advisory Council, an external board of global thought and business leaders, which provided insight and guidance to the company’s executive leadership on issues critical to the business and the world. Prior to joining AB InBev, Dr. Goldberg worked at the consulting firm Abt Associates and held positions as a researcher at the International Center for AIDS Care and Treatment Programs at Columbia University. She also served as a consultant in Johnson & Johnson’s Global Health Division, working with the Vice President of Global Health, to promote public health policy programs. A recognized expert in public health, Dr. Goldberg earned an interdisciplinary Ph.D. in Public Health and Political Science from Columbia University and a B.A. in Political Science from the University of Michigan. She is a 2015 Aspen Ideas Festival Scholar and holds an academic appointment as Lecturer at Columbia University.
Trevor Gunn, Ph.D., is Vice President of International Relations for Medtronic, the world’s largest medical technology company. Dr. Gunn was formerly long-time Director of the Commerce Department’s Business Information Service for the Newly Independent States, the clearinghouse for U.S. government information for doing business in the former Soviet Union. He has served continuously for the past 24 years as Adjunct Professor at the Center for Eurasian, Russian and East European Studies/School of Foreign Service, Georgetown University. He is a Vicennial Silver Medalist. He received his B.A. from the University of San Francisco. He received his Ph.D. in International Relations from the London School of Economics in 1992. He has worked with the Chamber of Commerce of Southern Sweden, Dover Elevator Corporation (now ThyssenKrupp of Germany), and International Executive Service Corps, and on the staffs of the former San Francisco Mayor and two U.S. Senators from California. He is the Founder and Chairman of the USA Healthcare
Alliance. He sits on the U.S. Department of State’s Stakeholder Advisory Board on the Organisation for Economic Co-operation and Development Guidelines on Corporate Social Responsibility and is an official Advisor to the Office of the U.S. Trade Representative in the “Industry Trade Advisory” system of the U.S. government. Dr. Gunn chairs the International Affairs Committee at Medtech Europe, Europe’s largest medical technology trade association. Furthermore, he is a Member of the Board of Directors for the U.S.–Russia Business Council and is Chair of the Executive Council on Diplomacy. He sits on the Washington Export Council (Washington, DC), the Board of Advisers of the Washington International Business Council, and the Board of the Center for Citizens Initiatives (San Francisco). He is also a member of the Health and Medicine Division’s Forum on Public–Private Partnerships for Global Health and Safety and is a member of the U.S. Department of Commerce’s District Export Council (Virginia). Finally, he serves on the Advisory Board of the University of Minnesota Carlson Business School’s Carlson Global Institute. Dr. Gunn speaks Swedish, French, and Russian.
Mark Halliday, M.B.A., is a health care subject-matter expert based in Washington, DC. He is the global lead of the International Finance Corporation’s (IFC’s) advisory team focused on health care public–private partnerships (PPPs). As part of the management team, he also works with other infrastructure teams to deliver on the IFC’s and World Bank Group’s objectives. Previously, Mr. Halliday was the Head of PPPs at Philips Healthcare. Before that, he worked at KPMG Corporate Finance in the Global Infrastructure and Projects Group, advising governments and private clients on the implementation of infrastructure projects worldwide, including the arrangement and restructuring of debt facilities. He has commercial and public-sector experience, having been appointed to the Business Advisory Board of the United Nations Economic Commission for Europe and having spent 8 years at the UK National Audit Office as their corporate finance advisor covering health care, energy, general infrastructure, and financing.
Carel IJsselmuiden, M.D., M.P.H., FFCH (SA), is a physician, epidemiologist, public health practitioner, academic, and social entrepreneur. After spending 10 years in rural medicine, peri-urban and urban health care, and environmental health services management, he switched to academic public health research, education, and research ethics training. He has published widely in applied research and public health and was appointed as professor and Head of the Department of Community Health at the University of Pretoria in 1995, where he became the founding director of the School of Health Systems and Public Health in 1999.
He held this position until his appointment as Executive Director at the Council on Health Research for Development (COHRED) in 2004. As such, he is also an ex-officio member of the COHRED Board and President of COHRED USA. Dr. IJsselmuiden has worked and lived in Africa, Europe, the United States, and the Caribbean.
Jim Jones is the Executive Director of the ExxonMobil Foundation. In this capacity, he oversees ExxonMobil Foundation’s major grant-making programs in global health (specifically in the fight against malaria), women’s economic opportunities, and U.S. math and science education. Previously, he directed ExxonMobil’s global brand, advertising, and integrated communications work. Prior to work in the private sector, Mr. Jones was the founding executive vice president at the Vaccine Fund (now Gavi, the Vaccine Alliance). He was also vice president of programs and policy at the Children’s Defense Fund, where he oversaw the organization’s work on education, juvenile justice, child welfare, and health. For 12 years, Mr. Jones served in various capacities in the U.S. Congress, including as director of communications and policy to Senator John F. Kerry, for whom he drafted major global health legislation, including the original federal spending authorizations for many product development partnerships. Mr. Jones is a graduate of Georgetown University and Oxford University and was awarded a Fulbright Scholarship to study international economics at the University of Munich.
Nduku Kilonzo, Ph.D., is passionate about promoting health and well-being of young people and women in Africa. As the Chief Executive Officer of the Kenya National AIDS Control Council (NACC), she is responsible for policy guidance, tracking progress and overall results of Kenya’s HIV response as outlined in Kenya’s HIV Strategic Framework, and for driving the NACC mandate while observing institutional accountability and compliance. Through her HIV work in Kenya and membership in many global technical and leadership forums and commissions, Dr. Kilonzo has made contributions that earned her acknowledgment in the Millennium Development Goal 6 Global Report. She has in the recent past been a member of the Global Review Panel of the Joint United Nations Programme on HIV and AIDS Operating Model in 2017 and the UN/Lancet Global Commission on the Future of Health in Sub-Saharan Africa. A Doctor of Philosophy holder in Tropical Medicine from the Liverpool School of Tropical Medicine, Dr. Kilonzo’s professional experience spans the government, the United Nations, and private sectors with more than 20 years in public health and development. She has led policy formulation and implementation of innovative public health programs in HIV and gender-based violence prevention and control programs in
Botswana, Côte d’Ivoire, Kenya, and Malawi. An avid reader and principal or co-investigator in many studies, Dr. Kilonzo has more than 30 peer-reviewed publications in high-impact-factor journals, commissioned reports, and book chapters in the areas of HIV prevention and control for Africa.
Liza Kimbo, M.B.A., M.Sc., has more than 20 years of experience in senior- and executive-level management, mainly focused on health-related programs. Her passion is in developing enterprises that serve the health care needs of the poor. Ms. Kimbo is Kenyan and has a B.S. in Finance, an M.B.A. (United States International University), and an M.Sc. in Health Systems Management from the London School of Hygiene & Tropical Medicine. Ms. Kimbo’s career spans the banking industry, health care business start-ups, and both nonprofit and for-profit organizations. She established the first primary care health franchise organization in Kenya—CFWclinics owned by Healthstore Foundation. She thereafter founded LiveWell Ltd., a chain of seven clinics and one mid-size hospital that provides low-income earners in Kenya with convenient, assured quality and affordable health care services.
Ties Kroezen, M.A., is a business development manager in the primary care business of Philips, with a focus on Africa. He specializes in developing new business models for primary care, especially public–private partnership models. In the first phase of his career, Mr. Kroezen was a business and strategy consultant working for a.o. Accenture and KPMG. He moved on to become a social entrepreneur in Africa, setting up and leading businesses in agriculture, solar, and information technology. Mr. Kroezen has a master’s degree in business science from the University of Twente, the Netherlands. He is a regular speaker on primary care and doing business in Africa.
Ambassador (Retired) John E. Lange, J.D., M.S., is the Senior Fellow for Global Health Diplomacy at the United Nations Foundation. Prior to joining the Foundation in July 2013, Lange spent four years at the Bill & Melinda Gates Foundation working with African governments to improve public health. He served as co-chair of the Global Polio Eradication Initiative’s Polio Partners Group from 2012 to 2016. He also served as co-chair of the National Academies’ Committee on Investing in Health Systems in Low- and Middle-Income Countries and currently serves as a member of its Committee on Enhancing Global Health Security through International Biosecurity and Health Engagement Programs. Ambassador Lange had a 28-year career in the Foreign Service at the U.S. Department of State, including service as Special Representative on Avian and Pan-
demic Influenza; Deputy U.S. Global AIDS Coordinator at the inception of The U.S. President’s Emergency Plan for AIDS Relief; and Ambassador to Botswana, where HIV/AIDS was his signature issue. He led the U.S. Embassy in Dar es Salaam during the August 7, 1998, terrorist bombing, for which he received the State Department’s Distinguished Honor Award. Ambassador Lange earlier had tours of duty in Geneva, Lomé, Paris, and Mexico City. He has written numerous articles, including an account of pandemic influenza negotiations for a book of case studies in global health diplomacy. He has degrees from the National War College, the University of Wisconsin Law School, and the University of Wisconsin–Madison. He speaks English and Spanish and has working proficiency in French.
Amy Lin, M.B.A., M.A., is the Acting Deputy Director at the U.S. Agency for International Development’s Center for Innovation and Impact (CII), where she focuses on such market-based strategies as introduction planning, market shaping, and innovative financing to accelerate adoption of high-priority health interventions. Previously, Ms. Lin was based in Mumbai with Monitor Inclusive Markets, where she developed social enterprise models that provide clean drinking water in slums. Prior to this role, Ms. Lin served as the HIV/AIDS Program Director for the Clinton Health Access Initiative (CHAI) in Liberia. Before CHAI, Ms. Lin was at the World Bank’s Development Marketplace, which funds new approaches to serving the poor. Previously, Ms. Lin worked with TechnoServe in Peru, advising microbusinesses on expansion, marketing, and operational strategies to target new customer segments. Earlier, Ms. Lin was based in New York with the Boston Consulting Group, a strategy consulting firm, where she advised multinational companies in the pharmaceutical, financial services, and consumer goods industries. Ms. Lin holds an M.B.A. from the Wharton School of the University of Pennsylvania, an M.A. in International Relations from the Johns Hopkins School of Advanced International Studies, and a B.A. with Distinction in Political Science from Yale University.
Matthew MacGregor, M.A., is the Senior Project Lead for Sustainability, Transition, and Co-Financing at The Global Fund to Fight AIDS, Tuberculosis and Malaria. In this capacity, Mr. MacGregor leads the Global Fund’s work to implement the Sustainability, Transition, and Co-Financing policy. Mr. MacGregor also previously served as a Fund Portfolio Manager for the Global Fund in the Latin American and Caribbean region, where he managed Global Fund grants to various countries. Before joining the Global Fund, Mr. MacGregor worked in health and development in Latin America, South East Asia, and the United States, including as the Execu-
tive Director of a U.S.-based health nongovernmental organization. He was selected as a 2008 Henry Luce Scholar, graduated Summa Cum Laude from Tufts University, and holds a master’s degree from the Fletcher School of Law and Diplomacy at Tufts.
Benjamin Makai leads the Technology for Development unit at Safaricom Ltd., which works with like-minded organizations to form partnerships aimed at identifying issues and finding solutions in areas such as health, agriculture, education, and disaster management. He is responsible for building and maintaining winning partnerships with ecosystem industry stakeholders. Mr. Makai has a B.Sc. in Computer Science from Egerton University, various developing leadership capabilities training from Strathmore Business School, and was recently awarded a certificate of completion for the Rethinking Financial Inclusion Program from Harvard Business School.
Rebecca Martin, Ph.D., serves as the Director of the Center for Global Health at the U.S. Centers for Disease Control and Prevention (CDC). Dr. Martin has worked both domestically and internationally in immunization, HIV, and health system strengthening and now leads CDC’s global efforts to protect and improve health globally through science, policy, partnership, and evidence-based public health action. Dr. Martin has more than 20 years of experience working in global health, having had CDC assignments in Kenya, Tanzania, and Denmark. Dr. Martin began her career with CDC in 1997 in the National Immunization Program, Epidemiology, and Surveillance Division. Prior to joining CDC, she worked at the Maryland Department of Hygiene and Mental Health in Baltimore, Maryland, as the immunization program epidemiologist.
Olasupo Oyedepo, B.Sc., is the Project Director of the Health Strategy and Delivery Foundation’s ICT4HEALTH Project in Nigeria. The project has provided technical assistance and support to the Federal Ministries of Health and of Communications and other stakeholders to operationalize the country’s National eHealth Strategy. He is also the Director of the African Alliance of Digital Health Networks, a peer-learning network to support the digital health ecosystem in Africa.
Muhammad Pate, M.D., M.B.A., is CEO of Big Win Philanthropy. Dr. Pate was Minister of State for Health of the Federal Republic of Nigeria from July 2011 to July 2013, and he led the successful Presidential Task Force on Polio Eradication in Nigeria and developed the results-based initiative Save One Million Lives. From 2013 to 2015, Dr. Pate was a visiting Professor at Duke University’s Global Health Institute. Previously, Dr. Pate
served as the Chief Executive of Nigeria’s Primary Health Care Development Agency and worked for several years at the World Bank Group in Washington, DC. He is a founding co-chair of the Board of the Private Sector Health Alliance in Nigeria and serves on Merck’s Advisory Board for Merck for Mothers, Harvard’s Defeating Malaria Initiative, the FHI 360 Advisory Board, and the World Economic Forum Global Agenda Council on Demographic Dynamics. He has received the Geneva Health Forum Award for 2014 and Harvard Health Leadership Award for 2012. Dr. Pate is certified by the American Board of Internal Medicine in the specialty of Internal Medicine and subspecialty of infectious diseases. He also holds an M.B.A. in Health Sector Management Concentration.
Kerry Pelzman, M.P.H., is a Senior Foreign Service Officer with 30 years of experience in public health, two-thirds of which has been spent with the U.S. Agency for International Development (USAID). She has served in six USAID missions, covering health, education, and capacity development, including in South Africa, Afghanistan, India, Iraq, the Regional Mission for Central Asia, and Russia. Prior to joining USAID in 1998, Ms. Pelzman was an international health consultant, worked to implement a family planning program in Togo, managed public health education programs for the New York City Department of Health, and served as a U.S. Peace Corps Volunteer in Mauritania. She received a Bachelor of Arts degree from Yale University and a Master’s of Public Health degree from the University of Michigan’s School of Public Health.
Leandro Piquet, M.A., Ph.D., is a professor of the Institute of International Relations of the University of São Paulo (USP), where he is coordinator of the Nucleus of Research in Public Policies, a research program focused on security and crime, and a member of the Group of Analysis of the International Conjuntura of the same university. Dr. Piquet was a professor in the Department of Political Science at USP (2000 to 2009) and a visiting researcher at the Taubman Center at the John F. Kennedy School of Government, Harvard University (2006 to 2007). He is an economist with a degree from the Federal University of Rio de Janeiro and a specialization in quantitative research methods from the University of Michigan’s Inter University Consortium for Political and Social Research. Dr. Piquet holds a master’s degree and a Ph.D. in Political Science from Instituto Universitário de Pesqisas do Rio de Janeiro and did postdoctoral studies at the Department of Political Science at USP. He is a member of the City Council of Rio de Janeiro and the Strategic Affairs Unit of the Advisory Office for Strategic Affairs of the Government of the State of São Paulo.
Johanna Ralston, M.A., M.P.H., has worked in global noncommunicable diseases (NCDs) and their risk factors for more than two decades. She has served as CEO of World Obesity Federation since 2017, focusing on changing the narrative and elevating obesity on the global agenda. From 2011 to 2016, Ms. Ralston served as CEO of the World Heart Federation, the main cardiovascular disease (CVD) organization in official relations with the World Health Organization (WHO) and a founder of the NCD Alliance. Ms. Ralston’s work included mobilizing the CVD community around the NCD agenda and WHO initiatives, including the Global Action Plan on NCDs from 2013 to 2020 and Global HEARTS, as well as a shared strategy to address rheumatic heart disease. Ms. Ralston also served as Vice Chair, steering group member, and Interim Director of the NCD Alliance during that period, and led the communications strategy for the 2011 UN high-level meeting and strategic planning for the second business plan. From 1999 until 2011, Ms. Ralston was the Vice President of Global Strategies at the American Cancer Society, overseeing global advocacy and building the global capacity-building program to strengthen community-based cancer and tobacco control in low- and middle-income countries. She is also a fellow at the Geneva Centre for Security Policy, leading the course on global health security. A dual citizen of Sweden and the United States, Ms. Ralston is an alumna of Harvard Business School and studied public health at Johns Hopkins University, after a first degree in literature. She serves on various committees and boards, including the Lung Cancer Alliance, the World Economic Forum Global Future of Health and Healthcare Council, the WHO NCD Civil Society Working Group, the WHO Expert Advisory Panel on Surgical Care, and the WHO Bloomberg NCD Business Case Expert Group.
Peter Sands, M.P.A., is the director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Since June 2015, Mr. Sands has been a research fellow at Harvard University, dividing his time between the Mossavar-Rahmani Center for Business and Government at the Harvard Kennedy School and the Harvard Global Health Institute, part of the Harvard T.H. Chan School of Public Health. Working on a range of research projects in financial markets and regulation, fintech, and global health, Mr. Sands’s engagement with global health issues includes chairing the U.S. National Academy of Medicine’s Commission on a Global Health Risk Framework for the Future, which in January 2016 produced the highly influential report The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Threats; chairing the World Bank’s International Working Group on financing preparedness, which in May 2017 published From Panic and Neglect to Investing in Health Security: Financing Preparedness at a National Level; authoring several papers on infectious disease crises
in the New England Journal of Medicine, The Lancet, and British Medical Journal; being the lead nonexecutive director between 2011 and 2017 on the Board of the United Kingdom’s Department of Health, which provides oversight and policy direction to the United Kingdom’s National Health Service; and being an active member on both the U.S. National Academy of Science’s Committee on Ensuring Access to Affordable Drugs and the Forum on Microbial Threats. Mr. Sands is a board member or advisor to several start-ups in the fintech and meditech arenas, such as Noble Markets (U.S.) and Cera (UK). He was the group chief executive of Standard Chartered PLC from November 2006 to June 2015. He joined the Board of Standard Chartered PLC as the group finance director in May 2002, responsible for finance, strategy, risk and technology, and operations. Prior to this, Mr. Sands was a senior partner at worldwide consultants McKinsey & Co. Before joining McKinsey, he worked for the United Kingdom’s Foreign and Commonwealth Office. He has served on various boards and commissions, including as a director of the World Economic Forum and co-chairman of Davos; governor of the United Kingdom’s National Institute for Economic and Social Research; member of the International Advisory Board of the Monetary Authority of Singapore; member of the Browne Commission on Higher Education Funding in the United Kingdom; member of the China People’s Association for Friendship with Foreign People’s Global CEO Council; co-chair of the UK–India CEO Forum; board director of the Institute of International Finance; chairman of the International Monetary Conference; member of the International Advisory Board of Lingnan University, China; and trustee of the Camden Roundhouse, London. Mr. Sands graduated from Brasenose College, Oxford University, with a first class degree in politics, philosophy, and economics. He also received a Master’s in Public Administration from Harvard University, where he was a Harkness Fellow.
Brendan Smith, M.Sc., leads the development of Vital Wave’s strategic insights and the application of its research and analytical approaches, drawing on his in-depth knowledge of international development and various industry sectors. He has particular expertise in digital health, having led the creation of landmark reports and digital health implementations across low- and middle-income countries, including Ethiopia, South Africa, Zambia, India, and Tanzania. For example, Mr. Smith led research on how national governments can play a fundamental role in coordinating key actors from both the public and the private sectors to establish successful national digital health systems. He has also been working with the East African Community on the design and implementation of a regional road map for digital health. Lastly, Mr. Smith brings a strong background in strategic needs assessments, competitive analyses, and
industry policy and regulation. This is complemented by his experience in field research and digital-for-development program implementation.
David Stanton, M.A., is a public health leader and the former Director of the U.S. Agency for International Development’s (USAID’s) Office of HIV/AIDS. He has 19 years of experience working with USAID’s HIV/AIDS program and more than 30 years of experience in public health, including working on sexually transmitted infections, HIV and AIDS treatment, and clinical epidemiology. Mr. Stanton has 4 years of overseas experience in West Africa. Additionally, he served on the transition team that established the Office of the U.S. Global AIDS Coordinator at the U.S. Department of State.
Ikuo Takizawa, M.Sc., graduated from the University of Tsukuba, Japan, in March 1992 with a B.A. in International Relations and then obtained his M.Sc. in Population and International Health from the Harvard T.H. Chan School of Public Health in June 1998. He joined the Japan International Cooperation Agency (JICA) in April 1992 and has since been involved in JICA’s health and health-related projects in Asia, Latin America, and Africa. He worked in JICA Philippines between 2001 and 2005 as an assistant resident representative in charge of health, education, and local governance. Between 2008 and 2010, he served in JICA Kenya as a regional project formulation advisor for health and was involved in designing, monitoring, and evaluating JICA’s health projects in Africa. Currently, he serves as deputy director general of the Human Development Department and oversees JICA’s health portfolio in Africa, the Middle East, Europe, and Latin America. Technically, he supervises JICA’s operations in health systems, strengthening including universal health coverage and infectious diseases control covering health emergency preparedness and response.
Katherine Taylor, Ph.D., M.Sc., is the Associate Director and Director of Global Health Training, Eck Institute for Global Health, University of Notre Dame. Trained as a parasite immunologist, Dr. Taylor’s research experience includes 14 years living and working in Kenya where she was employed by the U.S. Centers for Disease Control and Prevention and the International Livestock Research Institute focused on malaria and trypanosomiasis in livestock. She joined the National Institute of Allergy and Infectious Diseases in 2001. There, she established and led a new Drug Development Section within the Office of Biodefense that funded a portfolio of contracts for the development of new drugs against high-priority biothreats (e.g., smallpox, anthrax, and botulinum toxin). In 2009 she joined the University of Notre Dame’s Eck Institute for Global
Health. Dr. Taylor manages a number of international research relationships across a range of geographic locations, partners, and activities. Dr. Taylor also serves as the Director of Global Health Training, with primary responsibility for establishing and now leading the Master of Science in Global Health program. She is a past-President of the American Society of Tropical Medicine and Hygiene Committee for Global Health, and is a member of the National Academies’ Forum on Public–Private Partnerships for Global Health and Safety. She serves on the Advisory Board of the Catholic Medical Mission Board and on the Catholic Health Association International Outreach Committee.
Chris West, Ph.D., is a co-founder of Sumerian Partners (www.sumerianpartners.com). As the former Director of the Shell Foundation, an independent charity, he helped incubate and scale up a portfolio of social enterprises operating in emerging economies. He is the author of various reports, including Shell Foundation’s Enterprise Solutions to Poverty (2005), Enterprise Solutions to Scale (2010), and Accelerating Access to Energy (2014).
This page intentionally left blank.